Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 34

Sort by

Sort Order Select

Journal Articles

Safety and Efficacy of Adding Venetoclax to Reduced Intensity Conditioning Chemotherapy Prior to Allogeneic Hematopoietic Cell Transplantation in Patients with High Risk Myeloid Malignancies

Blood (2020) 136 (Supplement 1): 38–39.

https://doi.org/10.1182/blood-2020-134947

Published: 2020

Journal Articles

Gene expression–based discovery of atovaquone as a STAT3 inhibitor and anticancer agent

Blood (2016) 128 (14): 1845–1853.

https://doi.org/10.1182/blood-2015-07-660506

Published: 2016

Includes: Supplemental data

Journal Articles

Reconstitution Of EBV-Specific Immunity In Adult Recipients Of Double Cord Blood Transplantation Depends On SCF and IL-7 Levels and Maintenance Of a Diverse TCR Repertoire

Ioannis Politikos, MD, Haesook Kim, PhD, Sarah Nikiforow, MD, PhD, Anoma Nellore, MD, Lequn Li, MD, PhD, Sean McDonough, Robert J. Soiffer, MD, Joseph H. Antin, MD, Karen K. Ballen, MD, Corey S. Cutler, MD, MPH, FRCPC, Jerome Ritz, MD, Vassiliki A. Boussiotis, MD, PhD

Blood (2013) 122 (21): 3302.

https://doi.org/10.1182/blood.V122.21.3302.3302

Published: 2013

Journal Articles

Prostaglandin E 2 (PGE 2 ) Alters the Molecular and Functional Properties of Umbilical Cord Blood T Cells Via Modulating Wnt/β-Catenin Signaling

Lequn Li, MD, PhD, Anoma Nellore, MD, Sean McDonough, Ioannis Politikos, MD, Haesook Kim, PhD, Sarah Nikiforow, MD, PhD, Joseph H. Antin, MD, Karen K. Ballen, MD, Corey Cutler, MD, MPH, FRCPC, Jerome Ritz, MD, Vassiliki A. Boussiotis, MD, PhD

Blood (2012) 120 (21): 226.

https://doi.org/10.1182/blood.V120.21.226.226

Published: 2012

Journal Articles

Recovery of Thymic Epithelial Cells and T Cell Immune Reconstitution After Cord Blood Transplantation in Adults Depends On Angiogenesis and Neovascularization

Ioannis Politikos, MD, Haesook Kim, PhD, Julia Brown, PhD, Sean McDonough, Lequn Li, MD, PhD, Corey Cutler, MD, MPH, FRCPC, Joseph H. Antin, MD, Karen K. Ballen, MD, Jerome Ritz, MD, Vassiliki A. Boussiotis, MD, PhD

Blood (2012) 120 (21): 4175.

https://doi.org/10.1182/blood.V120.21.4175.4175

Published: 2012

Journal Articles

Engraftment Syndrome After Allogeneic Hematopoietic Cell Transplantation: Relationship to Acute Gvhd and Impact on Transplant Outcomes

Aazim Kamal Omer, MD, Bhargavi Yalamarti, MD, Haesook Kim, PhD, Steven L. McAfee, MD, Bimalangshu R. Dey, MD, Karen K. Ballen, MD, Eyal C. Attar, MD, Yi-Bin A. Chen, MD, Thomas R Spitzer, MD

Blood (2011) 118 (21): 3013.

https://doi.org/10.1182/blood.V118.21.3013.3013

Published: 2011

Journal Articles

Cytogenetics Abnormalities Predict the Outcome of Allogeneic Transplantation In AML: A CIBMTR Study

Philippe Armand, MD, PhD, Waleska Perez, MPH, Mei-Jie Zhang, PhD, Haesook Kim, PhD, Thomas R. Klumpp, MD, Paola Dal Cin, PhD, Edmund K Waller, MD, PhD, Mark R. Litzow, MD, Jane L. Liesveld, MD, Hillard M. Lazarus, MD, FACP, Andrew Artz, MD, MS, Vikas Gupta, MD, MRCP, FRCPath, Bipin N. Savani, MD, Philip L. McCarthy, MD, Jean-Yves Cahn, MD, Harry Schouten, Jurgen Finke, MD, Edward D. Ball, MD, Mahmoud Aljurf, MD, Corey Cutler, MD, MPH, FRCPC, Jacob M. Rowe, Joseph H. Antin, MD, Luis M Isola, MD, Paolo Di Bartolomeo, MD, Bruce Camitta, MD, Alan M Miller, MD, PhD, Mitchell S. Cairo, MD, Keith E. Stockerl-Goldstein, MD, Jorge Sierra, MD, Mary Lynn Savoie, MD, FRCPC, Joerg Halter, MD, Patrick J Stiff, MD, Chadi Nabhan, MD, FACP, Ann A. Jakubowski, MD, PhD, Donald Bunjes, MD, Effie W. Petersdorf, MD, Steven M Devine, MD, Richard Maziarz, MD, Martin Bornhauser, MD, Victor A Lewis, MD, David I. Marks, MBBS, PHD, Christopher N Bredeson, MD, MSc, FRCPC, Robert Soiffer, MD, Daniel J. Weisdorf, MD

Blood (2010) 116 (21): 680.

https://doi.org/10.1182/blood.V116.21.680.680

Published: 2010

Journal Articles

Hyperlipidemia After Allogeneic Hematopoietic Stem Cell Transplantation.

Bradley W Blaser, MD, PhD, Haesook Kim, PhD, Jorge Plutzky, MD, Edwin Alyea, III, MD, Vincent Ho, MD, Corey Cutler, MD, MPH, Philippe Armand, MD, PhD, John Koreth, MBBS, DPhil, Joseph H. Antin, MD, Robert Soiffer, MD

Blood (2010) 116 (21): 3457.

https://doi.org/10.1182/blood.V116.21.3457.3457

Published: 2010

Journal Articles

Decreased Telomerase Activity In CD4 Regulatory T Cells Is Associated with Severity of Chronic Graft-Versus-Host Disease (cGVHD) After Hematopoietic Stem Cell Transplantation (HSCT)

Yutaka Kawano, MD, PhD, Haesook Kim, PhD, Ken-ichi Matsuoka, MD, PhD, Suzan Lazo-Kallanian, John Daley, Joseph H. Antin, MD, Robert Soiffer, MD, Jerome Ritz, MD

Blood (2010) 116 (21): 1257.

https://doi.org/10.1182/blood.V116.21.1257.1257

Published: 2010

Journal Articles

Prophylactic Rituximab After Allogeneic Stem Cell Transplantation Prevents Steroid-Requiring Chronic Graft-Vs.Host Disease

Corey Cutler, MD, MPH, FRCPC, Lixian Sun, MS, Haesook Kim, PhD, Stefanie Sarantopoulos, MD, PhD, Bhavjot Bindra, Yi-Bin Chen, MD, Jacalyn Rosenblatt, MD, MSc, Philippe Armand, MD, PhD, John Koreth, MBBS, DPhil, Vincent T. Ho, MD, Edwin P. Alyea, III, MD, Robert J. Soiffer, MD, Jerome Ritz, MD, Joseph H. Antin, MD

Blood (2010) 116 (21): 214.

https://doi.org/10.1182/blood.V116.21.214.214

Published: 2010

Journal Articles

Reduced Intensity Conditioning (RIC) with Double Umbilical Cord Blood Transplantation Has Similar Outcomes Compared to RIC Transplantation From Related or Unrelated Adult Donors

Yi-Bin Chen, MD, Julie Aldridge, Haesook Kim, PhD, Karen K Ballen, MD, Corey Cutler, MD, MPH, FRCPC, Grace Kao, MD, Deborah Liney, Edwin P Alyea, III, MD, Philippe Armand, MD, PhD, John Koreth, MBBS, DPhil, Jerome Ritz, MD, Robert J Soiffer, MD, Thomas Spitzer, MD, Joseph H. Antin, MD, Vincent T Ho, MD

Blood (2010) 116 (21): 2367.

https://doi.org/10.1182/blood.V116.21.2367.2367

Published: 2010

Journal Articles

Predictors of Response to Salvage Therapy for Advanced Chronic Lymphocytic Leukemia (ECOG Protocol 2903)

Neil E. Kay, Haesook Kim, PhD, Sanford Kempin, MD, Steven T. Rosen, MD, FRCPA, Hillard Lazarus, Diane F. Jelinek, PhD, Martin S. Tallman, MD

Blood (2010) 116 (21): 2463.

https://doi.org/10.1182/blood.V116.21.2463.2463

Published: 2010

Journal Articles

A Prospective Study of Iron Overload in Patients Undergoing Ablative Stem Cell Transplantation.

Philippe Armand, MD, PhD, Joanna Rhodes, Haesook Kim, PhD, Corey Cutler, MD, MPH, Vincent T. Ho, MD, John Koreth, MBBS, DPhil, Edwin P Alyea, III, MD, Robert J Soiffer, MD, Joseph H Antin, MD

Blood (2009) 114 (22): 3332.

https://doi.org/10.1182/blood.V114.22.3332.3332

Published: 2009

Journal Articles

GM-CSF Secreting Leukemia Cell Vaccination after Allogeneic Reduced Intensity Hematopoietic Stem Cell Transplantation for Advanced Myeloid Malignancies

Vincent Ho, MD, Glenn Dranoff, MD, Haesook Kim, PhD, Matthew Vanneman, Mildred Pasek, Corey Cutler, MD, John Koreth, MBBS, Edwin Alyea, MD, Joseph H Antin, MD, Ritz Jerome, MD, Robert J Soiffer, MD

Blood (2008) 112 (11): 825.

https://doi.org/10.1182/blood.V112.11.825.825

Published: 2008

Journal Articles

Development of CMV-SPECIFIC Immunity after Cord Blood Transplantation in Adults Depends on Reconstitution of Thymopoiesis and Regeneration of NAÏVE CD8+ T Cells

Blood (2008) 112 (11): 1167.

https://doi.org/10.1182/blood.V112.11.1167.1167

Published: 2008

Journal Articles

Treatment Type Determines Gene Expression Changes from Pretreatment (PTx) to Relapse (Rel) in Acute Promyelocytic Leukemia (APL).

Qingping Cui, PhD, Haesook Kim, PhD, Da-Cheng Zhou, MD,PhD, Peter H. Wiernik, MD, Martin S. Tallman, MD, Robert E. Gallagher, MD

Blood (2007) 110 (11): 3167.

https://doi.org/10.1182/blood.V110.11.3167.3167

Published: 2007

Journal Articles

Impaired Immune Reconstitution after Cord Blood Transplantation in Adults Is Associated with Delayed Recovery but Not Functional Impairment of CD8 + T Cells.

Julia Brown, PhD, Karen Ballen, MD, Sean McDonough, Xupeng Ge, MD, PhD, Kristen Stevenson, PhD, Haesook Kim, PhD, Carol Reynolds, Bimalangshu R. Dey, MD, PhD, Steve McAfee, MD, Eyal Attar, MD, Thomas Spitzer, MD, Corey Cutler, MD, Vincent Ho, MD, Edwin Alyea, MD, Robert Soiffer, MD, Joseph H. Antin, MD, Jerome Ritz, MD, Vassiliki A. Boussiotis, MD, PhD

Blood (2007) 110 (11): 1057.

https://doi.org/10.1182/blood.V110.11.1057.1057

Published: 2007

Journal Articles

Tacrolimus and Sirolimus without Methotrexate as Acute GVHD Prophylaxis after Matched Related Donor Reduced Intensity Conditioning (RIC) Stem Cell Transplantation (SCT).

Vincent T. Ho, MD, Haesook Kim, PhD, Shuli Li, MS, Corey Cutler, MD MPH, John Koreth, MBBS, Phillipe Armand, MD, Robert J. Soiffer, MD, Joseph H. Antin, MD, Edwin P. Alyea, MD

Blood (2007) 110 (11): 3046.

https://doi.org/10.1182/blood.V110.11.3046.3046

Published: 2007

Journal Articles

Increased Global Gene Promoter Methylation after Relapse (Rel) of Acute Promyelocytic Leukemia (APL) from All- trans Retinoic Acid (ATRA)-Containing Treatment Is Dissociated from Concurrent Gene Expression Changes.

Da-Cheng Zhou, MD, PhD, Qingping Cui, PhD, Haesook Kim, PhD, Reid Thompson, BS, John Greally, MD, PhD, Eric E. Bouhassira, PhD, Robert E. Gallagher, MD

Blood (2007) 110 (11): 2121.

https://doi.org/10.1182/blood.V110.11.2121.2121

Published: 2007

Journal Articles

GM-CSF Secreting Leukemia Cell Vaccinations after Allogeneic Reduced-Intensity Peripheral Blood Stem Cell Transplantation (SCT) for Advanced Myelodysplastic Syndrome (MDS) or Refractory Acute Myeloid Leukemia (AML).

Vincent Ho, MD, Glenn Dranoff, MD, Haesook Kim, PhD, Mildred Pasek, RN, Corey Cutler, MDMPH, Edwin Alyea, MD, John Koreth, MD, Joseph H. Antin, MD, Robert J. Soiffer, MD

Blood (2006) 108 (11): 3680.

https://doi.org/10.1182/blood.V108.11.3680.3680

Published: 2006

NARROW

Safety and Efficacy of Adding Venetoclax to Reduced Intensity Conditioning Chemotherapy Prior to Allogeneic Hematopoietic Cell Transplantation in Patients with High Risk Myeloid Malignancies

Gene expression–based discovery of atovaquone as a STAT3 inhibitor and anticancer agent

Reconstitution Of EBV-Specific Immunity In Adult Recipients Of Double Cord Blood Transplantation Depends On SCF and IL-7 Levels and Maintenance Of a Diverse TCR Repertoire

Prostaglandin E 2 (PGE 2 ) Alters the Molecular and Functional Properties of Umbilical Cord Blood T Cells Via Modulating Wnt/β-Catenin Signaling

Recovery of Thymic Epithelial Cells and T Cell Immune Reconstitution After Cord Blood Transplantation in Adults Depends On Angiogenesis and Neovascularization

Engraftment Syndrome After Allogeneic Hematopoietic Cell Transplantation: Relationship to Acute Gvhd and Impact on Transplant Outcomes

Cytogenetics Abnormalities Predict the Outcome of Allogeneic Transplantation In AML: A CIBMTR Study

Hyperlipidemia After Allogeneic Hematopoietic Stem Cell Transplantation.

Decreased Telomerase Activity In CD4 Regulatory T Cells Is Associated with Severity of Chronic Graft-Versus-Host Disease (cGVHD) After Hematopoietic Stem Cell Transplantation (HSCT)

Prophylactic Rituximab After Allogeneic Stem Cell Transplantation Prevents Steroid-Requiring Chronic Graft-Vs.Host Disease

Reduced Intensity Conditioning (RIC) with Double Umbilical Cord Blood Transplantation Has Similar Outcomes Compared to RIC Transplantation From Related or Unrelated Adult Donors

Predictors of Response to Salvage Therapy for Advanced Chronic Lymphocytic Leukemia (ECOG Protocol 2903)

A Prospective Study of Iron Overload in Patients Undergoing Ablative Stem Cell Transplantation.

GM-CSF Secreting Leukemia Cell Vaccination after Allogeneic Reduced Intensity Hematopoietic Stem Cell Transplantation for Advanced Myeloid Malignancies

Development of CMV-SPECIFIC Immunity after Cord Blood Transplantation in Adults Depends on Reconstitution of Thymopoiesis and Regeneration of NAÏVE CD8+ T Cells

Treatment Type Determines Gene Expression Changes from Pretreatment (PTx) to Relapse (Rel) in Acute Promyelocytic Leukemia (APL).

Impaired Immune Reconstitution after Cord Blood Transplantation in Adults Is Associated with Delayed Recovery but Not Functional Impairment of CD8 + T Cells.

Tacrolimus and Sirolimus without Methotrexate as Acute GVHD Prophylaxis after Matched Related Donor Reduced Intensity Conditioning (RIC) Stem Cell Transplantation (SCT).

Increased Global Gene Promoter Methylation after Relapse (Rel) of Acute Promyelocytic Leukemia (APL) from All- trans Retinoic Acid (ATRA)-Containing Treatment Is Dissociated from Concurrent Gene Expression Changes.

GM-CSF Secreting Leukemia Cell Vaccinations after Allogeneic Reduced-Intensity Peripheral Blood Stem Cell Transplantation (SCT) for Advanced Myelodysplastic Syndrome (MDS) or Refractory Acute Myeloid Leukemia (AML).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only